Ferrari MD, Reuter U, Goadsby PJ, Paiva da Silva Lima G, et al. Two-year efficacy and safety of erenumab in participants with episodic migraine and 2-4 prior preventive treatment failures: results from the LIBERTY study. J Neurol Neurosurg Psychiatry 2021 Nov 29. pii: jnnp-2021-327480.
PMID: 34845002